Effect of dyspepsia on survival: A longitudinal 10-year follow-up study

American Journal of Gastroenterology

Volumn 107, Issue 6, 2012, Pages 912-921

  Ford, Alexander C ^a,b   Forman, David ^c,d   Bailey, Alastair G ^a   Axon, Anthony T R ^a   Moayyedi, Paul ^e  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CAUSE OF DEATH; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IRRITABLE COLON; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL;

CAUSE OF DEATH; DYSPEPSIA; ENGLAND; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 84861907812     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2012.69     Document Type: Article

References (33)

1. Chey WD, Nojkov B, Rubenstein JH et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010;105:859-65.
2. Ford AC, Marwaha A, Lim A et al. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010;8:830-7.
3. Jones RH, Lydeard SE, Hobbs FD et al. Dyspepsia in England and Scotland. Gut 1990;31:401-5. (Pubitemid 20129436)
4. Moayyedi P, Forman D, Braunholtz D et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 2000;95:1448-55. (Pubitemid 30396301)
5. Saito YA, Locke GR, Talley NJ et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000;95:2816-24.
6. Ford AC, Forman D, Bailey AG et al. Who consults with dyspepsia? Results from a longitudinal ten-year follow-up study. Am J Gastroenterol 2007;102:957-65. (Pubitemid 46698219)
7. Ford AC, Forman D, Bailey AG et al. Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior. Am J Gastroenterol 2008;103:1229-39. (Pubitemid 351677964)
8. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. Br Med J 1989;298:30-2. (Pubitemid 19022888)
9. Koloski NA, Talley NJ, Boyce PM. Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 2002;97:2290-9.
10. Koloski NA, Talley NJ, Huskic SS et al. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003;17:841-51. (Pubitemid 36418882)
11. Halder SLS, Locke GR, Talley NJ et al. Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 2004;19:233-42. (Pubitemid 38174892)
12. Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000;95:67-71. (Pubitemid 30041537)
13. Mahadeva S, Yadav H, Rampal S et al. Risk factors associated with dyspepsia in a rural Asian population and its impact on quality of life. Am J Gastroenterol 2010;105:904-12.
14. Chang JY, Locke GR III, Mcnally MA et al. Impact of functional gastrointestinal disorders on survival in the community. Am J Gastroenterol 2010;105:822-32.
15. Moayyedi P, Feltbower R, Brown J et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Lancet 2000;355:1665-9. 16. Ford AC, Forman D, Bailey AG et al. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007;56:321-7. (Pubitemid 46579758)
16. Ford AC, Forman D, Bailey AG et al. Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study. Aliment Pharmacol Ther 2008;28:1013-20.
17. Moayyedi P, Duffett S, Braunholtz D et al. The Leeds dyspepsia questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther 1998;12:1257-62. (Pubitemid 28565967)
18. Colin-Jones DG, Bloom B, Bodemar G et al. Management of dyspepsia: report of a working party. Lancet 1988;331:576-9. (Pubitemid 18060490)
19. Talley NJ, Stanghellini V, Heading RC et al. Functional gastroduodenal disorders. Gut 1999;45 (Suppl 2):37-42.
20. Manning AP, Thompson WG, Heaton KW et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978;277:653-4. (Pubitemid 9004104)
21. Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson, ME, Fruberg CF (eds). Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Le Jacq Publishing: New York, 1984, pp 170-83.
22. Glise H, Hallerback B, Johansson B. Quality of life assessments in the evaluation of gastroesophageal reflux and peptic ulcer disease before, during and after treatment. Scand J Gastroenterol 1995;208:131-5.
23. Mearin F, Badia X, Balboa A et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155-61. (Pubitemid 32917583)
24. Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006;130:1480-91.
25. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
26. Wallander MA, Johansson S, Ruigomez A et al. Dyspepsia in general practice: incidence, risk factors, comorbidity and mortality. Fam Pract 2007;24:403-11. (Pubitemid 350142636)
27. El-Serag HB, Talley NJ. Systematic review: health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther 2003;18:387-93. (Pubitemid 37070236)
28. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the domestic/international gastroenterology surveillance study (DIGEST). Scand J Gastroenterol 1999;34 (Suppl 231):48-54. (Pubitemid 29510677)
29. Hahn BA, Kirchdoerfer LJ, Fullerton S et al. Patient perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life. Aliment Pharmacol Ther 1997;11:553-9. (Pubitemid 27286958)
30. Solmaz M, Kavuk I, Sayar K. Psychological factors in the irritable bowel syndrome. Eur J Med Res 2003;8:549-56.
31. Sykes MA, Blanchard EB, Lackner J et al. Psychopathology in irritable bowel syndrome: support for a psychophysiological model. J Behav Med 2003;26:361-72. (Pubitemid 36890202)
32. Talley NJ, Gabriel SE, Harmsen WS et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736-41.
33. Longstreth GF, Yao JF. Irritable bowel syndrome and surgery: a multivariate analysis. Gastroenterology 2004;126:1665-73. (Pubitemid 38736330)